Evidence map›Paper›PMID 34582332›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2022

The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients.

Shipra Taneja, Yanbo Guo, Marissa Slaven, Aly-Khan Lalani, Erynn Shaw, Camilla Tajzler, Sebastien Hotte, Anil Kapoor

Open access · diamondAbstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shipra TanejaDepartment of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada.
Yanbo GuoDepartment of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada.
Marissa SlavenDepartment of Family Medicine, Division of Palliative Care, McMaster University, Hamilton, ON, Canada.
Aly-Khan LalaniJuravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
Erynn ShawDepartment of Family Medicine, Division of Palliative Care, McMaster University, Hamilton, ON, Canada.
Camilla TajzlerDepartment of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada.
Sebastien HotteJuravinski Cancer Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
Anil KapoorDepartment of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada.
McMaster University · CAHamilton Health Sciences · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe legalization of recreational cannabis in Canada in 2018 has led to many patients being curious about the benefits of taking cannabis in conjunction with their cancer treatment. We investigated the perceptions among genitourinary (GU) cancer patients regarding cannabis use as part of their care plans.

methodsA survey was created to explore current cannabis use behaviors, reasons for cannabis use, and the beliefs of cannabis usefulness towards cancer-related care, including cancer treatment, among GU cancer patients. The survey was distributed across Canada online via RedCAP through social media platforms, email, and patient advocacy groups. The survey was active from August to December 2020.

resultsOf eighty-five responses, 52 met inclusion for analysis. Participants included 11 bladder, 26 kidney, and 15 prostate cancer patients. Many (48.1%) participants used cannabis daily and 75% had been using it for more than one year. Cannabis was consumed through oil-based products, edibles, and smoking. The most common reasons for using cannabis were cancer-related anxiety, to prevent cancer progression, cancer-related pain, recreational use, and other, non-cancer-related illness or symptoms. Participants believed cannabis improved their sleep (70.2%), anxiety (65.9%), and overall mood (72.3%). Most participants were either unsure (38.3%) or neutral (31.9%) in the belief that cannabis might decrease their cancer progression.

conclusionsGU cancer patients use cannabis for a variety of cancer- and non-cancer-related symptoms. Many patients believe cannabis has benefited their cancer-related symptoms. These findings highlight the importance of healthcare providers remaining familiar with current evidence on cannabis to support patient conversations about cannabis use.

Identifiers

PMID34582332
PMCPMC8932436
OpenAlexW3203615712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.